Composition for promoting hair growth
Camellia kaempferol glycoside composition addresses the limitations of existing hair loss treatments by promoting hair growth through dermal papilla cell proliferation and outer root sheath cell protection, offering a safe and effective solution for hair loss prevention.
Patent Information
- Application Number
- KR1020210135571
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-10-13
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2041-10-13
AI Technical Summary
Existing hair loss treatments, such as minoxidil and finasteride, have side effects and unclear mechanisms, necessitating the development of biological materials that promote hair growth with minimal risk.
A composition containing camellia kaempferol glycoside, derived from camellia oilseed meal, is used to promote hair growth by enhancing the proliferation of hair follicle cells and inhibiting the death of outer root sheath cells.
The camellia kaempferol glycoside composition effectively promotes hair growth and prevents hair loss by stimulating dermal papilla cells and protecting outer root sheath cells, with optimal concentrations and dosages minimizing scalp irritation.
Smart Images

Figure 112021116965599-PAT00017_ABST
Abstract
Description
Technology Field
[0001] This specification relates to a composition for promoting hair growth. Background Technology
[0002] Hair primarily serves a defensive function to protect the scalp from external stimuli such as ultraviolet rays, while also fulfilling an aesthetic role in expressing one's external image. However, in modern society, hair loss is occurring frequently due to natural factors such as environmental pollution and strong UV rays, as well as physiological factors such as stress and hormonal imbalances. Furthermore, unlike in the past when hair loss was limited to adult men, it is now appearing regardless of age or gender, creating a pressing need for materials to prevent and treat it.
[0003] The hair follicle, a physiological organ that produces hair, is involved in the growth, maintenance, and shedding of hair by repeating the hair cycle during post-birth development, which is divided into the anagen phase (when hair is produced and actively grows), the catagen phase (when hair degenerates), the telogen phase (when hair is maintained until shedding), and the exogen phase (when hair loss occurs).
[0004] Although the exact cause of hair loss has not been fully identified to date, factors such as inhibition of proliferation or decreased function of dermal papilla cells involved in hair cycle regulation, abnormality of the hair cycle due to the action of male hormones, abnormal changes in the hair cycle due to reduced blood flow to the scalp, drugs such as anticancer agents, mental stress, physical stimulation, and environmental pollution are being cited.
[0005] Dermal papilla cells, a type of specialized fibroblast within the hair bulb, are known to interact with various types of epithelial cells within the hair follicle and play an important role in the formation of the hair follicle, hair regeneration, and hair growth. Therefore, inhibiting the growth, proliferation, and apoptosis of dermal papilla cells is an important target for the development of drugs that maintain the hair growth phase and inhibit hair loss.
[0006] Minoxidil and finasteride, conventionally used as hair growth promoters and hair loss treatments, are accompanied by side effects such as systemic hair loss and decreased sexual function, and the specific mechanism of action of minoxidil has not yet been clearly elucidated. Therefore, there is a need to develop biological materials that promote the proliferation of hair papilla cells with minimal risk of side effects. Prior art literature
[0007] Republic of Korea Published Patent Application No. 10-2019-0091162 The problem to be solved
[0008] In one aspect, the present disclosure aims to provide a composition for promoting hair growth. means of solving the problem
[0009] In one aspect, the present invention provides a hair growth promoting composition comprising camellia kaempferol glycoside as an active ingredient.
[0010] In an exemplary embodiment, the camellia kaempferol glycoside may be extracted from camellia oilseed meal.
[0011] In an exemplary embodiment, the content of the camellia kaempferol glycoside may be 0.01 to 20 weight% with respect to the total weight of the composition.
[0012] In an exemplary embodiment, the camellia kaempferol glycoside may be administered at a dosage of 1 to 10 mg / kg / day.
[0013] In an exemplary embodiment, the hair growth promotion may be due to the promotion of proliferation of hair follicle cells.
[0014] In an exemplary embodiment, the hair follicle cell may be a hair papilla cell.
[0015] In an exemplary implementation example, the above hair growth promotion may be due to the inhibition of external root sheath cell death.
[0016] In an exemplary embodiment, the composition may be a topical skin composition.
[0017] In an exemplary embodiment, the composition may be a food, cosmetic, or pharmaceutical composition. Effects of the invention
[0018] In one aspect, the hair growth-promoting composition according to the present invention has excellent hair growth-promoting efficacy and can prevent hair loss.
[0019] In one aspect, the hair growth promoting composition according to the present invention can promote the proliferation of hair follicle cells and promote hair growth.
[0020] In one aspect, the hair growth-promoting composition according to the present invention can promote hair growth by inhibiting the death of external root sheath cells. Brief explanation of the drawing
[0021] Figure 1 is the result of analyzing a camellia kaempferol glycoside according to one embodiment of the present disclosure by chromatography. FIG. 2 is a graph showing the efficacy of a hair growth-promoting composition according to one embodiment of the present disclosure in promoting the proliferation of hair papilla cells. FIG. 3 is a graph showing the efficacy of inhibiting external root sheath cell death of a hair growth-promoting composition according to one embodiment of the present disclosure. FIG. 4 is a graph showing the antioxidant activity of a hair growth-promoting composition according to one embodiment of the present disclosure in external root sheath cells. FIG. 5 is a graph showing the hair growth results by a hair growth-promoting composition according to one embodiment of the present disclosure. FIG. 6 is a photograph showing the hair growth results by a hair growth-promoting composition according to one embodiment of the present disclosure. Specific details for implementing the invention
[0022] The present invention will be described in detail below.
[0023] In one aspect, the present invention provides a hair growth promoting composition comprising camellia kaempferol glycoside as an active ingredient.
[0024] In the present disclosure, the camellia is an evergreen tree of the tea family ( Camelliajaponica It refers to a plant that is mainly distributed in East Asia, including Korea. Oil is extracted from the seeds to make camellia oil, and the wood is used for furniture, crafts, etc. In the present disclosure, all parts of the camellia plant, such as roots, stems, leaves, and flowers, may be used, and the entire plant may also be used.
[0025] In the present disclosure, the camellia kaempferol glycoside is a kaempferol glycoside derived from camellia, which may be prepared by extracting an extract from camellia using a solvent and removing impurities, sugars, and proteins from the extract using an ion exchange resin, but is not limited thereto. Such camellia kaempferol glycoside may not contain saponin components.
[0026] In one embodiment, the camellia kaempferol glycoside may be extracted from camellia oilseed meal.
[0027] In one embodiment, the solvent may be water, an organic solvent, or a mixture thereof. The organic solvent may include, but is not limited to, C1-C6 alcohols, acetone, hexane, ethyl acetate, carbon dioxide, or a mixture thereof.
[0028] In one embodiment, the camellia kaempferol glycoside may include one or more selected from the group consisting of camellia kaempferol triplysates and camellia kaempferol tetraglycerides.
[0029] In one embodiment, the camellia kaempferol triplysate may include one or more selected from the group consisting of compound 1 of formula 1, compound 2 of formula 2, compound 3 of formula 3, and compound 4 of formula 4.
[0030] [Chemical Formula 1]
[0031]
[0033] [Chemical Formula 2]
[0034]
[0036] [Chemical Formula 3]
[0037]
[0039] [Chemical Formula 4]
[0040]
[0041] In one embodiment, the compound 1 may be Kaempherol-3-O-β-D-xylopyranosyl(1→3)-O-α-L-rhamnopyranosyl(1→6)-O-β-D-galactopyranoside. The compound 2 may be Tsubakioside A. The compound 3 may be Kaempherol-3-O-α-L-rhamnopyranosyl(1→6)-O-β-D-xylopyranosyl-(1→2)-O-β-D-galactopyranoside. The compound 4 may be Camelliaside B.
[0042] In one embodiment, the camellia kaempferol tetraglyceride may include one or more selected from the group consisting of compound 5 of formula 5, compound 6 of formula 6, compound 7 of formula 7, and compound 8 of formula 8.
[0043] [Chemical Formula 5]
[0044]
[0046] [Chemical Formula 6]
[0047]
[0049] [Chemical Formula 7]
[0050]
[0052] [Chemical Formula 8]
[0053]
[0055] In one embodiment, the compound 5 may be Tsubakioside C. The compound 6 may be Tsubakioside B. The compound 7 may be Tsubakioside D. The compound 8 may be Kaempherol-3-O-β-D-xylopyranosyl(1→3)-O-α-L-rhamnopyranosyl(1→6)-O-β-D-galactopyranosyl-(1→2)-O-β-D-glucopyranoside.
[0056] In one embodiment, the weight ratio of the camellia kaempferol triploid and the camellia kaempferol tetraglobule may be 1:1 to 2. For example, the weight ratio of the camellia kaempferol triploid and the camellia kaempferol tetraglobule may be 1:1 to 2, 1:1.2 to 2, 1:1.4 to 2, 1:1.4 to 1.8, or 1:1.6 to 1.8.
[0057] In one embodiment, the content of the camellia kaempferol glycoside may be 0.01 to 20 weight% based on the total weight of the composition. If the content of the camellia kaempferol glycoside is less than 0.01 weight%, the hair growth promoting efficacy is reduced, and if it exceeds 20 weight%, irritation to the scalp may become severe. Specifically, the content of the camellia kaempferol glycoside is 0.01 wt% or more, 0.02 wt% or more, 0.03 wt% or more, 0.04 wt% or more, 0.05 wt% or more, 0.1 wt% or more, 0.2 wt% or more, 0.3 wt% or more, 0.4 wt% or more, 0.5 wt% or more, 0.6 wt% or more, 0.7 wt% or more, 0.8 wt% or more, 0.9 wt% or more, 1 wt% or more, 1.5 wt% or more, 2 wt% or more, 2.5 wt% or more, 3 wt% or more, 3.5 wt% or more, 4 wt% or more, 4.5 wt% or more, or 5 wt% or more, based on the total weight of the composition, and is 20 wt% or less, 19.5 wt% or less, 19 wt% or less, 18.5 wt% or less, 18 wt% or less, 17.5 wt% or less. It may be 17 weight% or less, 16.5 weight% or less, 16 weight% or less, 15.5 weight% or less, or 15 weight% or less.
[0058] In one embodiment, the camellia kaempferol glycoside may be administered at a dosage of 1 to 10 mg / kg / day. If the dosage of the camellia kaempferol glycoside is less than 1 mg / kg / day, the hair growth promoting efficacy is reduced, and if it exceeds 10 mg / kg / day, skin irritation may become severe. Specifically, the camellia kaempferol glycoside is 1 mg / kg / day or more, 1.1 mg / kg / day or more, 1.2 mg / kg / day or more, 1.3 mg / kg / day or more, 1.4 mg / kg / day or more, 1.5 mg / kg / day or more, 1.6 mg / kg / day or more, 1.7 mg / kg / day or more, 1.8 mg / kg / day or more, 1.9 mg / kg / day or more, 2 mg / kg / day or more, 2.1 mg / kg / day or more, 2.2 mg / kg / day or more, 2.3 mg / kg / day or more, 2.4 mg / kg / day or more, 2.5 mg / kg / day or more, 2.6 mg / kg / day or more, 2.7 mg / kg / day or more, 2.8 mg / kg / day or more, 2.9 mg / kg / day or more, 3 mg / kg / day or more, 3.1 mg / kg / day ≥, 3.2 mg / kg / day, ≥3.3 mg / kg / day, ≥3.4 mg / kg / day, or ≥3.5 mg / kg / day, and ≤10 mg / kg / day, ≤9.9 mg / kg / day, ≤9.8 mg / kg / day, ≤9.7 mg / kg / day, ≤9.6 mg / kg / day, ≤9.5 mg / kg / day, ≤9.4 mg / kg / day, ≤9.3 mg / kg / day, ≤9.2 mg / kg / day, ≤9.1 mg / kg / day, ≤8 mg / kg / day, ≤8.9 mg / kg / day, ≤8.8 mg / kg / day, ≤8.7 mg / kg / day, ≤8.6 mg / kg / day, ≤8.5 mg / kg / day, ≤8.4 mg / kg / day, ≤8.3 mg / kg / day, 8.2 It may be administered at doses of mg / kg / day or less, 8.1 mg / kg / day or less, 8 mg / kg / day or less, 7.5 mg / kg / day or less, or 7 mg / kg / day or less.
[0059] In one embodiment, the hair growth promotion may be achieved by promoting the proliferation of hair follicle cells. The hair follicle cells may be dermal papilla cells. Dermal papilla cells interact with various types of epithelial cells within the hair follicle and play an important role in the formation of the hair follicle, hair regeneration, and hair growth. The composition according to the present invention can promote the proliferation of dermal papilla cells, thereby promoting hair growth and preventing hair loss.
[0060] In one embodiment, the hair growth promotion may be achieved by inhibiting the death of outer root sheath cells. Outer root sheath cells are cells that protect hair generated in the hair bulb until keratinization is completely finished and transport it to the epidermis; the composition according to the present disclosure can inhibit the death of such outer root sheath cells, thereby promoting hair growth.
[0061] In one embodiment, the route of administration of the composition is not limited, but preferably may be transdermal or external.
[0062] In one embodiment, the composition may be a cosmetic composition. The cosmetic composition may have, for example, a softening lotion, an astringent lotion, a nourishing lotion, a nourishing cream, a massage cream, an eye cream, an eye essence, an essence, a cleansing cream, a cleansing lotion, a cleansing foam, a cleansing water, a pack, a powder, a body lotion, a body cream, a body essence, a body cleanser, a hair dye, a shampoo, a rinse, a hair styling agent, a hair growth agent, an ointment, a gel, a cream, a patch, a spray, a powder, and a skin-adhesive type, but is not limited thereto.
[0063] In addition, for each formulation, other ingredients other than the essential ingredients mentioned above may be appropriately selected and combined by a person skilled in the art without difficulty, depending on the type or purpose of use of other external preparations.
[0064] The above cosmetic composition may be provided in any formulation suitable for topical application. For example, it may be provided in the form of a solution, an emulsion obtained by dispersing an oil phase in an aqueous phase, an emulsion obtained by dispersing an aqueous phase in an oil phase, a suspension, a solid, a gel, a powder, a paste, a microneedle, a foam, or an aerosol composition. Compositions of such formulations may be prepared according to conventional methods in the art.
[0065] In addition to the compounds of this specification, the cosmetic composition according to this specification may further include functional additives and ingredients included in general cosmetic compositions. The functional additives may include ingredients selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, high molecular weight peptides, high molecular weight polysaccharides, sphingolipids, and seaweed extracts. The cosmetic composition according to this specification may include other ingredients that can provide a synergistic effect to the main effect, preferably within a range that does not impair the main effect. Furthermore, the cosmetic composition according to this specification may further include moisturizers, emollients, surfactants, UV absorbers, preservatives, disinfectants, antioxidants, pH adjusters, organic and inorganic pigments, fragrances, cooling agents, or limiting agents. The amount of the above ingredients can be easily selected by a person skilled in the art within a range that does not impair the purpose and effect of this specification, and the amount may be 0.001 to 10 weight%, specifically 0.01 to 3 weight%, based on the total weight of the composition.
[0066] In one embodiment, the composition may be a food composition. The formulation of the food composition is not particularly limited, but may be formulated, for example, into tablets, granules, pills, powders, liquids such as drinks, caramels, gels, bars, tea bags, etc. For each formulation of the food composition, in addition to the active ingredient, ingredients commonly used in the field can be appropriately selected and combined by a person skilled in the art according to the formulation or purpose of use without difficulty, and a synergistic effect may occur when applied simultaneously with other raw materials.
[0067] A food composition according to one embodiment may include various nutrients, vitamins, minerals (electrolytes), flavoring agents such as synthetic and natural flavoring agents, coloring agents and promoters (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonating agents used in carbonated beverages, etc. Additionally, food compositions according to one embodiment may include fruit pulp for the production of natural fruit juices, fruit juice beverages, and vegetable beverages. These ingredients may be used independently or in combination. Although the proportion of these additives is not particularly important, they are generally included in the range of 0 to about 50 parts by weight per 100 parts by weight of the composition according to one embodiment.
[0068] In one embodiment, the composition may be a pharmaceutical composition. The pharmaceutical composition may be administered orally, parenterally, rectally, topically, transdermally, intravenously, intramuscularly, intraperitoneally, subcutaneously, etc. Formulations for oral administration may be tablets, pills, soft and hard capsules, granules, powders, granules, liquids, emulsions, or pellets, but are not limited thereto. Formulations for parenteral administration may be solutions, suspensions, emulsions, gels, injections, drops, suppositories, patches, or sprays, but are not limited thereto. The above formulation can be easily prepared according to conventional methods in the field and may additionally include surfactants, excipients, wettable powders, emulsification promoters, suspending agents, salts or buffers for osmotic pressure control, coloring agents, spices, stabilizers, preservatives, preservatives, or other commonly used auxiliary agents.
[0069] In one aspect, the present disclosure provides a method for promoting hair growth or preventing hair loss, comprising the step of administering a composition containing an effective amount of camellia kaempferol glycoside to an individual requiring hair growth promotion or prevention of hair loss. In one aspect, the administration of the method may be performed according to the administration method and dosage described in the present disclosure.
[0070] In one aspect, the present disclosure provides a use of camellia kaempferol glycoside for preparing a composition for promoting hair growth.
[0071] In one aspect, the present invention provides a hair growth promoting use of camellia kaempferol glycoside.
[0072] The present invention will be described in more detail below through examples and the like. These examples are solely for the purpose of illustrating the present invention, and it will be obvious to those skilled in the art that the scope of the present invention is not to be interpreted as being limited by these examples.
[0074] [Example 1] Preparation of Camellia Campherol Glycoside
[0075] 1 kg of camellia oil cake (Jeju Island) was cold-pressed to remove oil, and 8 kg of 70% ethanol was added. Extraction was performed at 60°C for 8 hours using a heated extractor, and the mixture was filtered using a filter press to obtain camellia oil cake extract. The camellia oil cake extract was vacuum concentrated at 50–60°C using a rotary vacuum concentrator until the solid content was approximately 50%, yielding 200 g of concentrate. The concentrate was diluted with purified water to achieve a solid content of 10%. This solution was loaded into a glass tube column filled with 2 L of ion exchange resin (HP-20), washed with 10 L of purified water to remove impurities, sugars, and proteins, and then 10 L of 30% ethanol was passed through to obtain an eluent. The eluent was vacuum-concentrated and freeze-dried to obtain 20 g of camellia kaempferol glycoside powder. The camellia kaempferol glycoside powder obtained in this manner was dissolved in 70% ethanol and fractionated by reverse-phase chromatography under conditions of 0.1% TFA water / 0.1% TFA acetonitrile to separate the components contained in each fraction. The separated components were compounds 1 to 4, which are camellia kaempferol triploids, and compounds 5 to 8, which are camellia kaempferol tetraglycers. It was determined that compounds 1 to 8 each have structures of chemical formulas 1 to 8. The results of the reverse-phase chromatography are shown in Table 1 and Figure 1.
[0076] [Chemical Formula 1]
[0077]
[0079] [Chemical Formula 2]
[0080]
[0082] [Chemical Formula 3]
[0083]
[0085] [Chemical Formula 4]
[0086]
[0087] [Chemical Formula 5]
[0088]
[0090] [Chemical Formula 6]
[0091]
[0093] [Chemical Formula 7]
[0094]
[0096] [Chemical Formula 8]
[0097]
[0099] Retention time (minutes) area(%) Compound 5 + Compound 7 33.800 28.99 Compound 6 35.760 11.13 Compound 8 37.067 23.28 Compound 1 + Compound 2 45.585 18.92 Compound 3 + Compound 4 46.846 17.67
[0100] [Experimental Example 1] Evaluation of efficacy in promoting hair follicle dermal papilla cell proliferation
[0101] Hair follicle papilla cells were isolated from human occipital scalp tissue using a microscope and cultured for 14 days in culture dishes coated with collagen type 1. After culturing for 72 hours in DMEM (Dulbecco's modified eagles medium; HyClone GE Healthcare) containing antibiotics (1%), fungizone (0.1%), and 20% FBS, under conditions of 5% CO2 and 37°C, the medium was replaced with DMEM medium containing 10% FBS. When the cells had grown to more than 90% of the dish, the cultured cells were collected using 0.25% trypsin / 10mM EDTA (Welgene), cultured for 72 hours (until the cells had grown to more than 90% of the dish) in DMEM medium containing 10% FBS, under conditions of 5% CO2 and 37°C, and then provided for subsequent experiments.
[0102] The cultured hair follicle papilla cells were inoculated into a 96-well plate at a density of 2,000 cells / well and cultured for 24 hours under 5% CO2 at 37°C. Then, the camellia kaempferol glycosides of Example 1 were treated at various concentrations (1 ppm, 2 ppm, 5 ppm, 10 ppm, 20 ppm, 50 ppm) and cultured for 72 hours under 5% CO2 at 37°C. An untreated group was used as the control. Subsequently, the cells were cultured with CCK-8 (DONGJIN) for 2 hours, and the absorbance was measured at 450 nm using a microplate reader. Based on the measured absorbance, the relative cell viability was calculated by setting the control value to 100 and is shown in Figure 2.
[0104] [Experimental Example 2] Evaluation of Inhibitory Efficacy on External Root Sheath Cell Apoptosis
[0105] Outer root sheath cells were isolated from human occipital scalp tissue using a microscope and cultured for 14 days in culture dishes coated with collagen type 1. After culturing for 72 hours in a culture medium containing DMEM (Dulbecco's modified eagles medium; HyClone GE Healthcare) supplemented with antibiotics (1%), fungizone (0.1%), and 20% FBS, under conditions of 5% CO2 and 37°C, the medium was replaced with epilife medium containing EDGS. When the cells had grown to more than 90% of the dish, the cultured cells were collected using 0.25% trypsin / 10mM EDTA (Welgene), placed in epilife medium containing EDGS, and cultured for 72 hours (until the cells had grown to more than 90% of the dish) before being used for subsequent experiments.
[0106] After treating with the camellia kaempferol glycoside from Example 1 at various concentrations (1 ppm, 2 ppm, 5 ppm) for 4 hours, DKK1, H2O2, and TGF beta 2, known hair loss inducing factors, were added, followed by overnight incubation. Subsequently, the samples were cultured with CCK-8 (DONGJIN) for 2 hours, after which the absorbance was measured at 450 nm using a microplate reader. Relative cell viability was calculated based on the measured absorbance, with the control group set to 100, and is shown in Figure 3. The control group represents the group that received no treatment.
[0108] [Experimental Example 3] Evaluation of Antioxidant Capacity in External Root Sheath Cells
[0109] In Experimental Example 2, the outer rhizome cells cultured for the experiment were inoculated into 8-chamber slides at a density of 10,000 cells / well and cultured for 24 hours under 5% CO2 at 37°C. After finishing additional culture following treatment with the camellia kaempferol glycoside (5 ppm) of Example 1, the cell culture medium was removed, and formalin solution was added to fix the cells at room temperature for at least 15 minutes. The fixative was removed, and the cells were washed three times for 3 minutes each with washing buffer (0.1% BSA in PBS). After leaving the cells at room temperature with permeabilization solution for 30 minutes, they were reacted with blocking buffer (0.1–1% BSA in PBS) at room temperature for 30–60 minutes. The antibody against the target protein (NRF2) was diluted in blocking buffer and left overnight at 4°C. After bringing the cells back to room temperature, the primary antibody solution was removed, and the cells were washed four times for 3 minutes each with washing buffer (0.1% BSA in PBS). A secondary antibody (conjugated with a fluorescent dye) capable of targeting the primary antibody was diluted in blocking buffer and reacted at room temperature for 2 hours. Afterward, a mounting solution was applied, the sample was covered with a cover glass to prevent air bubbles, and observed under a fluorescence microscope; the results are shown in Figure 4. An untreated group was used as the control.
[0110] As can be seen in Figure 4, when treated with camellia kaempferol glycosides, it was confirmed that the NRF2 protein, known as an antioxidant indicator (J Invest Dermatol. 2017 Feb;137(2):295-304, Oxidative Damage Control in a Human (Mini-) Organ: Nrf2 Activation Protects against Oxidative Stress-Induced Hair Growth Inhibition), moved into the nucleus of outer root sheath cells (the arrow in Figure 4 indicates the movement of the NRF2 protein into the nucleus), and through this, it was found that camellia kaempferol glycosides can inhibit the death of outer root sheath cells.
[0112] [Experimental Example 4] Evaluation of hair follicle length growth efficacy
[0113] Twenty hair follicle samples were isolated per group from a 57-year-old woman for experimental application. The isolated hair follicle samples were cultured in 24-well plates at a rate of six per well on 500 µl of William's E medium containing 2 mM L-glutamine, 10 ng / ml hydrocortisone, 1% antibiotics, and 0.1% fungizone. Camellia saponin B1 (0.1 ppm), camellia saponin B2 (0.1 ppm), and Example 2 (0.01 ppm, 0.1 ppm) were applied to the 24-well plates. Samples that were not treated were used as a control. The medium was changed every 2 to 3 days. Hair growth lengths were measured on days 2 and 5 and are shown in Fig. 5, and hair follicles were photographed using a stereomicroscope (Dongwon CNS, Korea) on day 7 and are shown in Fig. 6.
[0115] [Formulation Example 1] Soap
[0116] Soap was prepared using a conventional method according to the composition listed in Table 2 below.
[0117] ingredient Content Camellia camphorol glycoside 1.5 g titanium dioxide 0.5 g polyethylene glycol 1 g glycerin 0.5 g Ethylenediaminetetraacetic acid 0.5 g sodium 1 g pigment 0.2 g Soap scent 0.2 g Soap base 94.1 g
[0118] [Formulation Example 2] Liquid ampoule
[0119] A liquid ampoule was prepared using a conventional method according to the composition listed in Table 3 below.
[0120] ingredient Content Camellia camphorol glycoside 50 mg Indigestible maltodextrin 100 mg Citric acid 10 mg spices 5 mg purified water 28.5 g
[0121] [Formulation Example 3] Cream
[0122] A cream was prepared using a conventional method according to the composition listed in Table 4 below.
[0123] ingredient Content Camellia camphorol glycoside 3 g polyethylene glycol monostearate 4 g Self-emulsifying monostearic acid glycerin 10 g Cetyl alcohol 8 g Squalene 10 g Tri-2-actylhenic acid glyceryl 10 g sphingoglycolipid 2 g 1,3-Butylene Glycol 14 g purified water 189 g
[0124] [Formulation Example 4] Liquid formulation
[0125] A cosmetic liquid formulation was prepared using a conventional method according to the composition listed in Table 5 below.
[0126] ingredient Content Camellia camphorol glycoside 3 g hydroxyethylenecellulose 15 g Xanthan sword 4 g 1,3-Butylene Glycol 10 g glycerin 8 g sodium hyaluronate 5 g purified water 155 g
[0127] [Formulation Example 5] Soft capsule
[0128] 60 mg of camellia kaempferol glycoside, 160 mg of L-carnitine, 320 mg of soybean oil, 2 mg of palm oil, 8 mg of hydrogenated vegetable oil, 4 mg of yellow beeswax, and 6 mg of lecithin were mixed and filled into one capsule according to a conventional method to produce a soft capsule.
[0130] [Formulation Example 6] Tablet
[0131] 60 mg of camellia kaempferol glycoside, 500 mg of galactooligosaccharide, 80 mg of lactose, and 220 mg of maltose were mixed and granulated using a fluid bed dryer, then 6 mg of sugar ester was added and the mixture was compressed using a tablet press to produce tablets.
[0133] [Formulation Example 7] Granules
[0134] 60 mg of camellia kaempferol glycoside, 250 mg of anhydrous crystalline glucose, and 550 mg of starch were mixed, formed into granules using a fluid bed granulator, and then filled into a bag to produce a granulated product.
[0136] [Formulation Example 8] Drink
[0137] 60 mg of camellia kaempferol glycoside, 10 g of glucose, 0.6 g of citric acid, and 25 g of liquid oligosaccharide were mixed, and 500 ml of purified water was added to fill each bottle with 200 ml. After filling the bottles, the mixture was sterilized at 130°C for 4 to 5 seconds to produce a drinkable beverage.
[0139] The present disclosure is further explained by the following embodiments that do not limit the scope of the claims.
[0140] Embodiment 1. A hair growth promoting composition comprising camellia kaempferol glycoside as an active ingredient.
[0141] Example 2. A composition of Example 1, wherein the camellia kaempferol glycoside is extracted from camellia oilseed meal.
[0142] Embodiment 3. Any of the compositions among Embodiments 1 to 2, wherein the camellia kaempferol glycoside comprises one or more selected from the group consisting of camellia kaempferol triploid and camellia kaempferol tetragloss.
[0143] Embodiment 4. Any of the compositions among Embodiments 1 to 3, wherein the content of the camellia kaempferol glycoside is 0.01 to 20 weight% based on the total weight of the composition.
[0144] Embodiment 5. Any of the compositions among Embodiments 1 to 4, wherein the camellia kaempferol glycoside is administered at a dosage of 1 to 10 mg / kg / day.
[0145] Embodiment 6. Any of the compositions among Embodiments 1 to 5, wherein the hair growth promotion is due to the proliferation of hair follicle cells.
[0146] 7. A composition of Embodiment 6, wherein the hair follicle cells are hair papilla cells.
[0147] Embodiment 8. Any of the compositions in Embodiments 1 to 7, wherein the hair growth promotion is achieved by inhibiting the death of outer root sheath cells.
[0148] Example 9. Any of the compositions in Examples 1 to 8, wherein the composition is a skin external application composition.
[0149] Embodiment 10. Any of the compositions among Embodiments 1 to 9, wherein the composition is a food composition.
[0150] Embodiment 11. Any composition among Embodiments 1 to 10, wherein the composition is a cosmetic composition.
[0151] Embodiment 12. Any of the compositions among Embodiments 1 to 11, wherein the composition is a pharmaceutical composition.
[0152] Embodiment 13. A method for promoting hair growth comprising the step of administering any composition of Embodiments 1 to 12 to an individual requiring hair growth promotion.
[0153] Embodiment 14. A method for preventing hair loss comprising the step of administering any composition of Embodiments 1 to 12 to an individual requiring prevention of hair loss.
Claims
Claim 1 A hair growth-promoting composition comprising a camellia kaempferol glycoside as an active ingredient, wherein the camellia kaempferol glycoside comprises one or more compounds selected from the group consisting of compounds represented by the following chemical formulas 1 to 8: [Chemical Formula 1] [Chemical Formula 2] [Chemical Formula 3] [Chemical Formula 4] [Chemical Formula 5] [Chemical Formula 6] [Chemical Formula 7] [Chemical Formula 8] Claim 2 A composition according to claim 1, wherein the camellia kaempferol glycoside is extracted from camellia oilseed meal. Claim 3 delete Claim 4 A composition according to claim 1, wherein the content of the camellia kaempferol glycoside is 0.01 to 20 weight% based on the total weight of the composition. Claim 5 A composition according to claim 1, wherein the camellia kaempferol glycoside is administered at a dosage of 1 to 10 mg / kg / day. Claim 6 A composition according to claim 1, wherein the hair growth promotion is due to the proliferation of hair follicle cells. Claim 7 In claim 6, the composition wherein the hair follicle cells are hair papilla cells. Claim 8 A composition according to claim 1, wherein the hair growth promotion is achieved by inhibiting the death of outer root sheath cells. Claim 9 A composition according to any one of claims 1, 2 and 4 through 8, wherein the composition is a skin external application composition. Claim 10 A composition according to any one of claims 1, 2 and 4 through 8, wherein the composition is a food composition. Claim 11 A composition according to any one of claims 1, 2 and 4 through 8, wherein the composition is a cosmetic composition. Claim 12 A composition according to any one of claims 1, 2 and 4 through 8, wherein the composition is a pharmaceutical composition.
Citation Information
Patent Citations
Hair cosmetic composition containing extract of Camellia japonica L. seed
KR1020130122070A
Hair restoration / hair growth promoter
JP2015131788A
